Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $33.7200 (5.24%) ($31.4700 - $34.1000) on Fri. Nov. 20, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.78% (three month average) | RSI | 64 | Latest Price | $33.7200(5.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(53%) ARKG(49%) IWO(48%) IWM(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.89% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-8%) UNG(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.89% (StdDev 5.78%) | Hourly BBV | 0 () | Intraday Trend | 3.8% | | | |
|
5 Day Moving Average | $32.04(5.24%) | 10 Day Moving Average | $32.45(3.91%) | 20 Day Moving Average | $30.46(10.7%) | To recent high | -5.6% | To recent low | 41.2% | Market Cap | $2.506b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |